PROFILE-MI - The FAPI Fibrosis Study
PROline and FapI With Late Gadolinium Enhancement in Myocardial Infarction PROFILE-MI - The FAPI Fibrosis Study
2 other identifiers
observational
80
1 country
1
Brief Summary
The investigators here propose to investigate the timing and pattern of myocardial fibrosis activity following acute myocardial infarction using hybrid 68Ga-FAPI positron emission tomography and cardiovascular magnetic resonance. The investigators hypothesise that peak fibrosis activity will occur within 2-4 weeks of acute myocardial infarction and will predict subsequent scar formation and cardiac remodelling. Simultaneously, matrix remodelling and fibrosis activity in aortic and coronary atheroma will be assessed enabling the exploration of the presence of unstable atheroma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 21, 2021
CompletedFirst Submitted
Initial submission to the registry
April 26, 2022
CompletedFirst Posted
Study publicly available on registry
May 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedMay 17, 2024
March 1, 2023
2.7 years
April 26, 2022
May 16, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Time of maximal fibrosis activity following myocardial infarction
SUVmax and TBR of 68Ga-FAPI uptake within the infarct, border zone, and remote myocardium
12 weeks
Whether fibrosis activity predicts myocardial scar volume and ventricular remodelling
As measured by CMR 12 months following acute MI
12 months
Fibrosis activity and myocardial remodelling within atherosclerotic plaque in patients with myocardial infarct
SUVmax and TBR of 68Ga-FAPI uptake within areas of atherosclerotic plaque in the aorta and/or carotid arteries
12 weeks
Study Arms (3)
Healthy volunteers
Age- and sex- matched to participants, those aged 50 or over without known heart disease. n=20
Acute myocardial infarction - multi-timepoint imaging
Those aged 50 or over with recent myocardial infarction who will be imaged using PET/MR at 1,2,4, and 12 weeks post-MI. n=20
Acute or chronic myocardial infarction - single timepoint imaging
Those aged 50 or over with recent (n=20) or prior established (\>24 months, n=20) myocardial infarction who will be imaged at a single timepoint (1,2,4, or 12 weeks post-MI for acute, at the time of enrolement to the study for chronic).
Interventions
68Gallium FAPI PET/MR scan
Eligibility Criteria
Healthy volunteer participants (cohort 1, n=20): those without significant or serious comordibity or known cardiac disease Participants with acute myocardial infarction (cohorts 2 and 3, n=40): ST-elevation myocardial infarction within 3 weeks of enrollment Participants with chronic myocardial infarction (n=20): ST-elevation myocardial infarction 24 months or more prior to enrollment
You may qualify if:
- specific to cohort;
- aged 50 years or older
You may not qualify if:
- Claustrophobia
- Inability to undergo MRI
- eGFR \<30ml/min/1.73\^m2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Royal Infirmary of Edinburgh
Edinburgh, City Of Edinburgh, EH16 4SA, United Kingdom
Related Publications (1)
Barton AK, Craig NJ, Loganath K, Joshi S, Tsampasian V, Mahendran M, Lenell J, Tzolos E, Singh T, Whittington B, Nash J, Williams MC, van Beek EJR, MacAskill MG, Berkeley B, Vezaides S, Brittan M, Baker AH, Sellers S, Fletcher A, Clark T, Waight C, Slart RHJA, Berman D, Dey D, Slomka P, Newby DE, Dweck MR. Myocardial Fibroblast Activation After Acute Myocardial Infarction: A Positron Emission Tomography and Magnetic Resonance Study. J Am Coll Cardiol. 2025 Feb 18;85(6):578-591. doi: 10.1016/j.jacc.2024.10.103. Epub 2025 Jan 8.
PMID: 39772364DERIVED
Biospecimen
Blood draw for all participants with recent or prior established myocardial infarction at each attendance for PET/MR scanning
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 26, 2022
First Posted
May 2, 2022
Study Start
April 21, 2021
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
May 17, 2024
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share